AstraZeneca COVID antibody combination to be manufactured by Samsung Biologics MD Bureau15 Dec 2021 3:37 PM ISTSeoul: British-Swedish pharmaceutical giant AstraZeneca on Tuesday said that Samsung Biologics, the biotech arm of Samsung Group, will manufacture its...
AstraZeneca in touch with Indian authorities for COVID drug Evusheld Ruchika Sharma10 Dec 2021 2:34 PM ISTEvusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US for COVID-19 pre-exposure...
AstraZeneca COVID antibody cocktail authorized by USFDA Ruchika Sharma9 Dec 2021 1:24 PM ISTUK: AstraZeneca has recently announced that Evusheld (tixagevimab co-packaged with cilgavimab), a Long-Acting Antibody (LAAB) combination, has...
Mixing AstraZeneca, Pfizer COVID shots with Moderna gives better immune response, claims study Ruchika Sharma8 Dec 2021 10:00 AM ISTNew Delhi: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of...
AstraZeneca receives CDSCO panel nod to conduct phase 3 trial of Trastuzumab Deruxtecan Roshni Dhar1 Dec 2021 3:47 PM ISTIn a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the Central...
AstraZeneca, Hutchmed begin phase 3 trial of Orpathys, Tagrisso combo in lung cancer patients Ruchika Sharma28 Nov 2021 10:30 AM ISTHong Kong: HUTCHMED (China) Limited and AstraZeneca PLC have initiated SACHI, a China Phase III study of ORPATHYS (savolitinib), an oral, potent, and...
Covid-19: AstraZeneca examining impact of new variant on its vaccine, antibody cocktail Ruchika Sharma27 Nov 2021 3:49 PM ISTLondon: AstraZeneca said on Friday it was examining the impact of a new coronavirus variant that is spreading rapidly in South Africa on its...
AstraZeneca's antibody shot 83% effective at preventing Covid MD Bureau21 Nov 2021 10:00 AM ISTLondon: A single shot of an antibody treatment against Covid-19 developed by UK drug major AstraZeneca is 83 per cent capable to reduce the risk of...
AstraZeneca to transfer Eklira, Duaklir rights to Covis Pharma for USD 270 million Ruchika Sharma5 Nov 2021 9:00 AM ISTUK: AstraZeneca has recently announced that the company has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in...
Serum Institute sees 'large' Covid-19 vaccine exports as output nearly quadruples Ruchika Sharma22 Oct 2021 12:46 PM ISTNew Delhi: The Serum Institute of India (SII), the world's biggest vaccine maker, has nearly quadrupled its monthly capacity of AstraZeneca shots...
AstraZeneca launches clinical data, insights division in India Ruchika Sharma20 Oct 2021 5:02 PM ISTNew Delhi: AstraZeneca India Private Limited, the Global Capability Centre (GCC) of AstraZeneca has launched a clinical data and insights division in...
Russia rebuffs claims of stealing AstraZeneca COVID vaccine formula MD Bureau14 Oct 2021 12:57 PM ISTNew York: Russia has rebuffed accusations that its spies stole the "blueprint" for the Oxford-AstraZeneca vaccine and used it to create its own...
